Lingyan Jiang
4PUBLICATIONS
107CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.Xing Wei, Cristina Blaj, M Ali Al-Radhawi
|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors.Caroline Weller, G Leslie Burnett, Lingyan Jiang
|Apr 29, 2025
A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma.Caroline Broderick, Riccardo Mezzadra, Exequiel M Sisso
|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato
Pageof 1
Frequent Collaborators
4 joint publications
Jingjing Jiang
4 joint publications
Mallika Singh
3 joint publications
Jacqueline A M Smith
3 joint publications
Matthew Holderfield
3 joint publications
Zhican Wang
2 joint publications
Benjamin J Maldonato
2 joint publications
Ida Aronchik
2 joint publications
Kyle Seamon
2 joint publications
James W Evans
2 joint publications
Xing Wei
